Seguir
Jinesh Gheeya
Título
Citado por
Citado por
Año
Widespread alternative exon usage in clinically distinct subtypes of invasive ductal carcinoma
SS Bjørklund, A Panda, S Kumar, M Seiler, D Robinson, J Gheeya, M Yao, ...
Scientific reports 7 (1), 5568, 2017
442017
Synthesis of novel cyclic NGR/RGD peptide analogs via on resin click chemistry
BB Metaferia, M Rittler, JS Gheeya, A Lee, H Hempel, A Plaza, ...
Bioorganic & medicinal chemistry letters 20 (24), 7337-7340, 2010
442010
Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers
B Garmezy, J Gheeya, HY Lin, Y Huang, T Kim, X Jiang, KZ Thein, ...
JCO Precision Oncology 6, e2100267, 2022
422022
Protein-lysine methyltransferases G9a and GLP1 promote responses to DNA damage
V Ginjala, L Rodriguez-Colon, B Ganguly, P Gangidi, P Gallina, ...
Scientific reports 7 (1), 16613, 2017
422017
Expression profiling identifies epoxy anthraquinone derivative as a DNA topoisomerase inhibitor
J Gheeya, P Johansson, QR Chen, T Dexheimer, B Metaferia, YK Song, ...
Cancer letters 293 (1), 124-131, 2010
372010
Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma
JS Gheeya, QR Chen, CD Benjamin, AT Cheuk, P Tsang, JY Chung, ...
Cancer biology & therapy 8 (24), 2386-2395, 2009
292009
Development of Peptide Nucleic Acid Probes for Detection of the HER2 Oncogene
B Metaferia, JS Wei, YK Song, J Evangelista, K Aschenbach, ...
PLoS One 8 (4), e58870, 2013
272013
Inference of germline mutational status and evaluation of loss of heterozygosity in high-depth, tumor-only sequencing data
H Khiabanian, KM Hirshfield, M Goldfinger, S Bird, M Stein, J Aisner, ...
JCO precision oncology 2, 1-15, 2018
202018
Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events
BA Siddiqui, JS Gheeya, R Goswamy, TK Bathala, DS Surasi, J Gao, ...
Journal for immunotherapy of cancer 9 (7), 2021
162021
Correlation of pathogenic POLE mutations with clinical benefit to immune checkpoint inhibitor therapy.
B Garmezy, JS Gheeya, KZ Thein, PG Pilie, W Wang, J Rodon Ahnert, ...
Journal of Clinical Oncology 38 (15_suppl), 3008-3008, 2020
152020
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors
T El Zarif, AH Nassar, GR Pond, TZ Zhuang, V Master, B Nazha, S Niglio, ...
JNCI: Journal of the National Cancer Institute 115 (12), 1605-1615, 2023
82023
Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers., 2022, 6, p. e2100267
B Garmezy, J Gheeya, HY Lin, Y Huang, T Kim, X Jiang, KZ Thein, ...
DOI: https://doi. org/10.1200/PO 21, 2018
62018
Paraneoplastic cerebellar degeneration (pcd) associated with PCA-1 antibodies in established cancer patients
MJ Lehner, JS Gheeya, BA Siddiqui, S Tummala
Journal of neuro-oncology 153 (3), 441-446, 2021
32021
Identifying functional loss of ATM gene in patients with advanced cancer.
PG Pilie, JS Gheeya, K Kyewalabye, RV Goswamy, KM Wani, H Le, ...
Journal of Clinical Oncology 38 (15_suppl), 3629-3629, 2020
12020
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types
PG Pilie, V Giuliani, WL Wang, DJ McGrail, CA Bristow, NYL Ngoi, ...
Clinical Cancer Research, OF1-OF19, 2024
2024
Associations of dietary patterns with kidney cancer risk, kidney cancer-specific mortality and all-cause mortality among postmenopausal women
Q Jin, J Gheeya, S Nepal, N Shi, E Folefac, MZ Webb, EM Grainger, L Wei, ...
British Journal of Cancer 129 (12), 1978-1987, 2023
2023
EP13. 05-01 Early ctDNA Changes and Clinical Outcomes in Extensive Stage Small Cell Lung Cancer Patients on Nivolumab and Temozolomide
JS Gheeya, L Wei, L Bucheit, C Pilcher, V Sukrithan, B Konda, ...
Journal of Thoracic Oncology 18 (11), S700-S701, 2023
2023
A Cost-effective Way to Merge Fitbit Devices into Clinical Trials: Older Adults with Lung Cancer
M Grogan, R Hoyd, J Gheeya, C Presley, D Spakowicz
Journal of Geriatric Oncology 14 (8), S14-S15, 2023
2023
Clinical outcomes of patients with bone-predominant metastatic renal cell carcinoma.
JS Gheeya, M Li, M Xu, DE Zimmerman, KA Collier, P Wang, E Folefac, ...
Journal of Clinical Oncology 41 (6_suppl), 703-703, 2023
2023
Nodular Regenerative Hyperplasia of the Liver Associated With Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor in a Patient With Metastatic Renal Cell Carcinoma
S Rudolph, M Li, J Gheeya, D Zimmerman, M Yin, SK Clinton, AV Parwani, ...
JCO Precision Oncology 7, 2023
2023
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20